Comparing laparoscopic and open resection in elderly hepatocellular carcinoma: a systematic review and meta-analysis

Abstract

Background: Laparoscopic liver resection (LLR) has been accepted as a safe and effective treatment for hepatocellular carcinoma (HCC). However, its impact on elderly patients remains uncertain. This study aimed to compare the efficacy and safety of LLR with open liver resection (OLR) in elderly HCC patients. Methods: We conducted a search across the Ovid-Medline, Ovid-EMBASE, and Cochrane Library to identify comparative studies involving primary HCC in elderly patients (≥65 years). Efficacy-related outcomes encompassed overall survival (OS) and disease-free survival (DFS), while safety-related outcomes included post-operative mortality, complications, and length of stay (LOS). Results: We identified nine eligible cohort studies comprising 1,599 patients. LLR demonstrated comparable 3- and 5-year DFS [hazard ratio (HR) =1.00, 95% confidence interval (CI): 0.98–1.02; HR =1.02, 95% CI: 0.99–1.05] and 3- and 5-year OS (HR =1.01, 95% CI: 0.99–1.02; HR =1.02, 95% CI: 0.99–1.06, respectively) compared to OLR. In terms of safety, there was no significant difference between LLR and OLR in in-hospital mortality [odds ratio (OR) =0.19; 95% CI: 0.02–1.69], 30-day mortality (OR =0.33; 95% CI: 0.03–3.20), and 90-day mortality (OR =0.70; 95% CI: 0.32–1.53). Additionally, LLR presented fewer overall complications (OR =0.53; 95% CI: 0.41–0.67), a lower rate of major complications (OR =0.51; 95% CI: 0.35–0.74), a reduced incidence of liver failure (OR =0.56; 95% CI: 0.33–0.94), and a shorter LOS compared to OLR (mean difference: −14.47 days). Conclusions: LLR exhibited comparable clinical efficacy and superior safety and fewer complications when compared to OLR in elderly patients with HCC requiring surgery.